<!-- <pre>{{_data | json}}</pre>  -->
<ng-container>
  <div class="card-header text-white rounded-lg">
    <div style="padding:7px; justify-content:space-between; display:flex;">
      {{resultTabs?.usApproval?.label}} >> SITAGLIPTIN PHOSPHATE{{_data?.name}}
      <button class="btn btn-warning"><i class="fa-solid fa-download"></i></button>
    </div>
  </div>


  <!-- <div class="card-header d-flex align-items-center p-2 text-white fs-5">
    <i class="fa-solid fa-flask"></i>
    <h1> ORANGE BOOK >> SITAGLIPTIN PHOSPHATE</h1>

    <i class="fa fa-refresh" aria-hidden="true"></i>

    <select class="form-select dropdown-width mx-1">
      <option>Select Ingredient</option>
      <option>ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE</option>
      <option>SITAGLIPTIN</option>
      <option>SITAGLIPTIN PHOSPHATE</option>
      <option> METFOMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE</option>
      <option>SIMVASTATIN;SITAGLIPTIN PHOSPHATE</option>

    </select>

    <select class="form-select dropdown-width mx-1">
      <option>Select RLD</option>
      <option>Yes</option>
    </select>

    <select class="form-select dropdown-width mx-1">
      <option>Select Appl Type</option>
      <option>N</option>
    </select>

    <select class="form-select dropdown-width mx-1">
      <option>Select Applicant</option>
      <option>MSD SUB MERCK</option>
      <option>ZYDUS LIFESCIENCES</option>
      <option>MERCK SHARP DOHME</option>



    </select>

    <select class="form-select dropdown-width mx-1">
      <option>Select Strength</option>
      <option>15MG;EQ 100MG BASE</option>
      <option>5MG;EQ 100MG BASE</option>
      <option>100MG</option>
      <option>50MG</option>
      <option>25MG</option>
      <option>EQ 25MG BASE</option>
      <option>EQ 50MG BASE</option>

      <option>AN EQ 100MG BASE</option>

      <option>Z 1GM;EQ 100MG BASE </option>

      <option>500MG;EQ 50MG BASE </option>

      <option>1GM;EQ 50MG BASE </option>

      <option>10MG;EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for
        safety or effectiveness reasons**</option>
      <option>20MG;EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for
        safety or effectiveness reasons**</option>
      <option>20MG;EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for
        safety or effectiveness reasons**</option>
      <option> 40MG;EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for
        safety or effectiveness reasons**</option>
      <option>40MG;EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for
        safety or effectiveness reasons** </option>
      <option>10MG;EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for
        safety or effectivenessÂ reasons**</option>


      <button class="btn btn-warning"><i class="fa-solid fa-download"></i></button>
    </select>
  </div> -->


  <div class="card body" style="background-color:#f8faff;">
    <div class="pb-3 mb-3 px-2 rounded-lg">

      <div class="row">

        <div class="col-xl-4 col-lg-4 col-md-4 col-sm-12">

          <div class="col-md-8 col-sm-9" *ngIf="_data?.green_book_registration_number">
            <h6 class="font-bold text-indigo-900">
              {{ getColumnName('green_book_registration_number') }}
              <span class="mx-1 hover:cursor-pointer text-[#0032A0]" #copyBtn
                (click)="handleCopy(_data?.green_book_registration_number, copyBtn)">
                <i class="fas fa-copy"></i>
              </span>
            </h6>
            <p class="text-wrap max-h-12 whitespace-normal">
              {{ _data?.green_book_registration_number }}
            </p>
          </div>
          <div class="col-md-5 col-sm-6" *ngIf="_data?.product_no">
            <h6 class="font-bold text-indigo-900">
              {{ getColumnName('product_no') }}
              <span class="mx-1 hover:cursor-pointer text-[#0032A0]" #copyBtn
                (click)="handleCopy(_data?.product_no, copyBtn)">
                <i class="fas fa-copy"></i>
              </span>
            </h6>
            <p class="text-wrap max-h-12 whitespace-normal">
              {{ _data?.product_no }}
            </p>
          </div>
          <div class="col-md-5 col-sm-6" *ngIf="_data?.trade_name">
            <h6 class="font-bold text-indigo-900">
              {{ getColumnName('trade_name') }}
              <span class="mx-1 hover:cursor-pointer text-[#0032A0]" #copyBtn
                (click)="handleCopy(_data?.trade_name, copyBtn)">
                <i class="fas fa-copy"></i>
              </span>
            </h6>
            <p class="text-wrap max-h-12 whitespace-normal">
              {{ _data?.trade_name }}
            </p>
          </div>

          <h6 class="font-bold text-indigo-900">COMPANY LOGO:</h6>
          <img src="assets/components/Merck.png" class="image1">

          <h6 class="font-bold text-indigo-900">ACTIVE INGREDIENT/COMBITION: <i
              class="fa-solid fa-copy hover:cursor-pointer" (click)="copyText('ACTIVE',$event)"
              title="Copy to clipboard"></i></h6>
          <p id="ACTIVE">ERTUGLIFLOZIN;SITAGLIPTIN PHOSPHATE</p>

          <h6 class="font-bold text-indigo-900">STRENGTH: <i class="fa-solid fa-copy hover:cursor-pointer"
              (click)="copyText('STRENGTH',$event)" title="Copy to clipboard"></i></h6>
          <p id="STRENGTH">15MG;EQ 100MG BASE</p>

          <h6 class="font-bold text-indigo-900">REFERENCE LISTED DRUG(RLD): <i
              class="fa-solid fa-copy hover:cursor-pointer" (click)="copyText('REFERENCE',$event)"
              title="Copy to clipboard"></i></h6>
          <p id="REFERENCE">Yes</p>

          <div class="col-md-5 col-sm-6" *ngIf="_data?.rs">
            <h6 class="font-bold text-indigo-900">
              {{ getColumnName('rs') }}
              <span class="mx-1 hover:cursor-pointer text-[#0032A0]" #copyBtn (click)="handleCopy(_data?.rs, copyBtn)">
                <i class="fas fa-copy"></i>
              </span>
            </h6>
            <p class="text-wrap max-h-12 whitespace-normal">
              {{ _data?.rs }}
            </p>
          </div>

        </div>

        <div class="col-xl-4 col-lg-4 col-md-4 col-sm-12" style="background-color: #f8faff;">


          <div class="col-md-5 col-sm-6" *ngIf="_data?.df">
            <h6 class="font-bold text-indigo-900">
              {{ getColumnName('df') }}
              <span class="mx-1 hover:cursor-pointer text-[#0032A0]" #copyBtn (click)="handleCopy(_data?.df, copyBtn)">
                <i class="fas fa-copy"></i>
              </span>
            </h6>
            <p class="text-wrap max-h-12 whitespace-normal">
              {{ _data?.df }}
            </p>
          </div>

          <div class="col-md-5 col-sm-6" *ngIf="_data?.route">
            <h6 class="font-bold text-indigo-900">
              {{ getColumnName('route') }}
              <span class="mx-1 hover:cursor-pointer text-[#0032A0]" #copyBtn
                (click)="handleCopy(_data?.route, copyBtn)">
                <i class="fas fa-copy"></i>
              </span>
            </h6>
            <p class="text-wrap max-h-12 whitespace-normal">
              {{ _data?.route }}
            </p>
          </div>
          <div class="col-md-5 col-sm-6" *ngIf="_data?.exclusivity_date">
            <h6 class="font-bold text-indigo-900">
              {{ getColumnName('exclusivity_date') }}
              <span class="mx-1 hover:cursor-pointer text-[#0032A0]" #copyBtn
                (click)="handleCopy(_data?.exclusivity_date, copyBtn)">
                <i class="fas fa-copy"></i>
              </span>
            </h6>
            <p class="text-wrap max-h-12 whitespace-normal">
              {{ _data?.exclusivity_date }}
            </p>
          </div>

          <div class="col-md-5 col-sm-6" *ngIf="_data?.exclusivity_code">
            <h6 class="font-bold text-indigo-900">
              {{ getColumnName('exclusivity_code') }}
              <span class="mx-1 hover:cursor-pointer text-[#0032A0]" #copyBtn
                (click)="handleCopy(_data?.exclusivity_code, copyBtn)">
                <i class="fas fa-copy"></i>
              </span>
            </h6>
            <p class="text-wrap max-h-12 whitespace-normal">
              {{ _data?.exclusivity_code }}
            </p>
          </div>

          <h6 class="font-bold text-indigo-900">TYPE: <i class="fa-solid fa-copy hover:cursor-pointer"
              (click)="copyText('TYPE',$event)" title="Copy to clipboard"></i></h6>
          <p id="TYPE">Rx</p>
          <img src="assets/components/fda.jpg" class="image2">


        </div>

        <div class="col-xl-4 col-lg-4 col-md-4 col-sm-12" style="background-color: #f8faff;">

          <div class="col-md-5 col-sm-6" *ngIf="_data?.appl_no">
            <h6 class="font-bold text-indigo-900">
              {{ getColumnName('appl_no') }}
              <span class="mx-1 hover:cursor-pointer text-[#0032A0]" #copyBtn
                (click)="handleCopy(_data?.appl_no, copyBtn)">
                <i class="fas fa-copy"></i>
              </span>
            </h6>
            <p class="text-wrap max-h-12 whitespace-normal">
              {{ _data?.appl_no }}
            </p>
          </div>

          <div class="col-md-5 col-sm-6" *ngIf="_data?.appl_type">
            <h6 class="font-bold text-indigo-900">
              {{ getColumnName('appl_type') }}
              <span class="mx-1 hover:cursor-pointer text-[#0032A0]" #copyBtn
                (click)="handleCopy(_data?.appl_type, copyBtn)">
                <i class="fas fa-copy"></i>
              </span>
            </h6>
            <p class="text-wrap max-h-12 whitespace-normal">
              {{ _data?.appl_type }}
            </p>
          </div>

          <h6 class="font-bold text-indigo-900">APPROVAL DATE: <i class="fa-solid fa-copy hover:cursor-pointer"
              (click)="copyText('APPROVALDATE',$event)" title="Copy to clipboard"></i></h6>
          <p id="APPROVALDATE">19-Dec-2017</p>


        </div>

      </div>
    </div>

  </div>

  <!-- ==============  Table-Header=========== -->

  <div class="overflow-x-auto ">
    <table class="w-full border border-gray-300 text-xs">
      <thead class="bg-gray-800 text-white">
        <tr>
          <!-- <th *ngFor="let key of getObjectKeys(us_column)">
            {{ getColumnName1(key) }}
          </th> -->
          <th class="px-2 py-1 text-left">Patent Claims</th>
          <th class="px-2 py-1 text-left">Product No.</th>
          <th class="px-2 py-1 text-left">Applicant No.</th>
          <th class="px-2 py-1 text-left">Patent Expiration</th>
          <th class="px-2 py-1 text-left">Delist Requested</th>
          <th class="px-2 py-1 text-left">Jarvis RN</th>
          <th class="px-2 py-1 text-left">Drug Substance</th>
          <th class="px-2 py-1 text-left">Drug Product</th>
          <th class="px-2 py-1 text-left">Patent Use Code</th>
          <th class="px-2 py-1 text-left">Submission Date</th>
          <th class="px-2 py-1 text-left">Remarks</th>
          <th class="px-2 py-1 text-left">Download Format</th>
        </tr>
      </thead>

      <tbody class="bg-white">
        <tr *ngFor="let item of _data.patentData" class="border-b border-gray-300 hover:bg-gray-100">
          <td class="px-2 py-1">{{ item.patent_no }}</td>
          <td class="px-2 py-1">
            <button 
              (click)="openPopup(item)" 
              class="button text-white text-xs px-2 py-1 rounded hover:bg-yellow-700" style="width:120px"
              data-bs-toggle="modal" 
              data-bs-target="#viewPatentModal">
              VIEW PATENT CLAIMS
            </button>
          </td>
          
          <td class="px-2 py-1">{{ item.product_no }}</td>
          <td class="px-2 py-1">{{ item.appl_no }}</td>
          <td class="px-2 py-1">{{ item.patent_expire_date_text }}</td>
          <td class="px-2 py-1">{{ item.delist_flag }}</td>
          <td class="px-2 py-1 overflow auto">{{ item.jarvis_rn }}</td>
          <td class="px-2 py-1">{{ item.drug_substance_flag }}</td>
          <td class="px-2 py-1">{{ item.drug_product_flag }}</td>
          <td class="px-2 py-1">{{ item.patent_use_code }}</td>
          <td class="px-2 py-1">{{ item.submission_date }}</td>
          <td class="px-2 py-1">{{ item.remark_s }}
            <button 
              (click)="openPopup(item)" 
              class="button text-white text-xs px-2 py-1 rounded hover:bg-yellow-700"
              data-bs-toggle="modal" 
              data-bs-target="#remarkModal">
              VIEW PATENT CLAIMS
            </button>
          </td>
          <td class="px-2 py-1">{{ item.pdf_csv_text_file_downloadable_format }}</td>

        </tr>
      </tbody>
    </table>

  </div>

  <div class="obexclusivitydata">

    <h4 class="obtext" style="padding: 25px 0 10px 0; font-size: 20px;">OB Exclusivity Data :</h4>

    <table class="w-full border border-gray-300">
      <thead class="bg-gray-800 text-white text-sm">
        <tr>
          <th class="px-2 py-1 text-left">Product</th>
          <th class="px-2 py-1 text-left">Product No.</th>
          <th class="px-2 py-1 text-left">Exclusive Code</th>
          <th class="px-2 py-1 text-left">Exclusive Expiration</th>
          <th class="px-2 py-1 text-left">Application No.</th>
          <th class="px-2 py-1 text-left">Application Type</th>
          <th class="px-2 py-1 text-left">Notes</th>
          <th class="px-2 py-1 text-left">Remarks</th>
          <th class="px-2 py-1 text-left">PDF, CSV, Text File downloadable format</th>
        </tr>
      </thead>
      <tbody style="background-color:#f8faff;">
        <tr class="border-b border-gray-300">
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm">2</td>
          <td class="px-2 py-1 w-[80px] text-sm">M-275</td>
          <td class="px-2 py-1 w-[80px] text-sm">17-Sep-2024</td>
          <td class="px-2 py-1 w-[80px] text-sm">209805</td>
          <td class="px-2 py-1 w-[80px] text-sm">N</td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
        </tr>
      </tbody>
    </table>
  </div>

  <hr style="border: 5px solid blue;">



  <!-- ===================2nd Details=================== -->


  <div class="card body">
    <div class="pb-3 mb-3 px-2 rounded-lg">

      <div class="row">

        <div class="col-xl-4 col-lg-4 col-md-4 col-sm-12" style="background-color:#f8faff;">

          <h5> <span style="color: blue;">2.</span> GREEN BOOK REGISTRATION NUMBER(GBRN): <i
              class="fa-solid fa-copy hover:cursor-pointer" (click)="copyText('GREENBOOK2',$event)"
              title="Copy to clipboard"></i></h5>
          <p id="GREENBOOK2">10083;10313</p>

          <h5>PRODUCT NUMBER: <i class="fa-solid fa-copy hover:cursor-pointer"
              (click)="copyText('PRODUCTNUMBER2',$event)" title="Copy to clipboard"></i></h5>
          <p id="PRODUCTNUMBER2">1</p>

          <h5>TRADE NAME: <i class="fa-solid fa-copy hover:cursor-pointer" (click)="copyText('TRADENAME2',$event)"
              title="Copy to clipboard"></i></h5>
          <p id="TRADENAME2">SITAGLIPTIN</p>

          <h5>COMPANY LOGO:</h5>
          <img src="assets/components/Merck.png" class="image1">

          <h5>ACTIVE INGREDIENT/COMBITION: <i class="fa-solid fa-copy hover:cursor-pointer"
              (click)="copyText('ACTIVEINGREDIENT2',$event)" title="Copy to clipboard"></i></h5>
          <p id="ACTIVEINGREDIENT2">ERTUGLIFLOZIN;SITAGLIPTIN PHOSPHATE</p>

          <h5>STRENGTH: <i class="fa-solid fa-copy hover:cursor-pointer" (click)="copyText('STRENGTH2',$event)"
              title="Copy to clipboard"></i></h5>
          <p id="STRENGTH2">15MG;EQ 100MG BASE</p>

          <h5>REFERENCE LISTED DRUG(RLD): <i class="fa-solid fa-copy hover:cursor-pointer"
              (click)="copyText('REFERENCE2',$event)" title="Copy to clipboard"></i></h5>
          <p id="REFERENCE2">Yes</p>

          <h5>REFERENCE STANDARD(RS): <i class="fa-solid fa-copy hover:cursor-pointer"
              (click)="copyText('REFERENCE3',$event)" title="Copy to clipboard"></i></h5>
          <p id="REFERENCE3">No</p>

        </div>

        <div class="col-xl-4 col-lg-4 col-md-4 col-sm-12" style="background-color: #f8faff;">


          <h5>DOSES FORM: <i class="fa-solid fa-copy hover:cursor-pointer" (click)="copyText('DOSES2',$event)"
              title="Copy to clipboard"></i></h5>
          <p id="DOSES2">TABLET</p>

          <h5>ROUTE: <i class="fa-solid fa-copy hover:cursor-pointer" (click)="copyText('ROUTE2',$event)"
              title="Copy to clipboard"></i></h5>
          <p id="ROUTE2"> ORAL</p>

          <h5>APPLICANT: <i class="fa-solid fa-copy hover:cursor-pointer" (click)="copyText('APPLICANT2',$event)"
              title="Copy to clipboard"></i></h5>
          <p id="APPLICANT2">MSD SUB MERCK</p>

          <h5>APPLICANT HOLDER FULL NAME: <i class="fa-solid fa-copy hover:cursor-pointer"
              (click)="copyText('APPLICANTHOLDER2',$event)" title="Copy to clipboard"></i></h5>
          <p id="APPLICANTHOLDER2">MERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC</p>

          <h5>TYPE: <i class="fa-solid fa-copy hover:cursor-pointer" (click)="copyText('TYPE2',$event)"
              title="Copy to clipboard"></i></h5>
          <p id="TYPE2">Rx</p>
          <img src="assets/components/fda.jpg" class="image2">


        </div>

        <div class="col-xl-4 col-lg-4 col-md-4 col-sm-12" style="background-color: #f8faff;">

          <h5>APPLICATION NUMBER: <i class="fa-solid fa-copy hover:cursor-pointer"
              (click)="copyText('APPLICATIONNUMBER2',$event)" title="Copy to clipboard"></i></h5>
          <p id="APPLICATIONNUMBER2">209805</p>

          <h5>APPLICATION TYPE: <i class="fa-solid fa-copy hover:cursor-pointer"
              (click)="copyText('APPLICATIONTYPE2',$event)" title="Copy to clipboard"></i></h5>
          <p id="APPLICATIONTYPE2">N</p>

          <h5>APPROVAL DATE: <i class="fa-solid fa-copy hover:cursor-pointer" (click)="copyText('APPROVALDATE2',$event)"
              title="Copy to clipboard"></i></h5>
          <p id="APPROVALDATE2"> 19-Dec-2017</p>


        </div>

      </div>
    </div>

  </div>

  <!-- ==============  Table-Header=========== -->

  <div class="overflow-x-auto ">
    <table class="w-full border border-gray-300">
      <thead class="bg-gray-800 text-white text-xs">
        <tr>
          <th class="px-2 py-1 text-left">Patent No.</th>
          <th class="px-2 py-1 text-left">Patent Claims</th>
          <th class="px-2 py-1 text-left">Product No.</th>
          <th class="px-2 py-1 text-left">Applicant No.</th>
          <th class="px-2 py-1 text-left">Patent Expiration</th>
          <th class="px-2 py-1 text-left">Delist Requested</th>
          <th class="px-2 py-1 text-left">Jarvis RN</th>
          <th class="px-2 py-1 text-left">Drug Substance</th>
          <th class="px-2 py-1 text-left">Drug Product</th>
          <th class="px-2 py-1 text-left">Patent Use Code</th>
          <th class="px-2 py-1 text-left">Submission Date</th>
          <th class="px-2 py-1 text-left">Remarks</th>
          <th class="px-2 py-1 text-left">PDF, CSV, Text File downloadable format</th>
        </tr>

      </thead>
      <!-- ==============  Table-Body 1st=========== -->

      <tbody style="background-color:#f8faff;">
        <tr class="border-b border-gray-300">

          <td class="px-2 py-1 w-1/6">
            <h6 class="text-blue-600 hover:underline"></h6>
            <div class="">
              <p class="text-[#2900FF] font-bold text-sm" style="color:#312e81;">US7326708</p>
              <a
                href="https://worldwide.espacenet.com/patent/search/family/041208284/publication/US8080580B2?q=US8080580">
                <img src="assets/components/espace.png" class="h-1" alt="Google">
              </a>
              <a href="https://patents.google.com/patent/US8080580">
                <img src="assets/components/GooglePatents.png" class="h-2" alt="Espace">
              </a>
            </div>
          </td>

          <td class="px-2 py-1 w-1/6">

            <button (click)="openPopup6()"
              class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
              VIEW PATENT CLAIMS
            </button>

            <div *ngIf="isPopupOpen6" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
              <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                <h2 class="text-lg font-bold" style="color:#312e81;">Patent Claims</h2>
                <hr>
                <p class="mt-2">
                  Patent Information:<span style="padding-left: 800px;"> <button (click)="closePopup6()"
                      class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
                  </span>
                  <br><br>

                  1. Patent Number: US7326708B2; US20050032804A1<br>
                  Assignee: MERCK SHARP &amp; DOHME ([US])<br>
                  Publication Date: 2008-02-05<br>
                  Application Number: US10/874,992<br>
                  Application Date: 2004-06-23<br>
                  Equivalents: WO2005/003135A1 2005-01-13 [WO200503135]; US7326708 B2 2008-02-05 [US7326708];
                  US20050032804A1 2005-02-10 [US20050032804]; EP1654263 B1 2007-09-12 [EP1654263]; EP1654263 B2
                  2011-02-23 [EP1654263]; EP1654263 A1 2006-05-10 [EP1654263]; CA2529400 C 2007-10-09 [CA2529400];
                  CA2529400 A1 2005-01-13 [CA2529400]; DE602004008938 D1 2007-10-25 [DE602004008938]; DE602004008938 T2
                  2008-08-07 [DE602004008938]; DE602004008938 T3 2012-01-12 [DE602004008938]; JP4463768 B2 2010-05-19
                  [JP4463768]; JP2006516268 A 2006-06-29 [JP2006516268]; AU2004253889 B2 2008-04-24 [AU2004253889];
                  AU2004253889 A1 2005-01-13 [AU2004253889]; TWI347185 B 2011-08-21 [TWI347185]; TW200524610 A
                  2005-08-01 [TW200524610]; IS2792B 2012-08-15 [IS---2792B]; IS8183A 2005-12-15 [IS---8183]; SG118516 B
                  2007-11-30 [SG-118516]; SG118516 A1 2006-02-28 [SG-118516]; KR10-1016569 B1 2011-02-22 [KR101016569];
                  KR10-2006-0026061 A 2006-03-22 [KR20060026061]; NO335371 B1 2014-12-01 [NO-335371]; NO20060362 L
                  2006-03-23 [NO20060362]; MA27861 A1 2006-04-03 [MA--27861]; EA009042 B1 2007-10-26 [EA---9042];
                  EA200600095 A1 2006-06-30 [EA200600095]; BRPI0411726 B1 2017-12-12 [BR200411726]; BRPI0411726 B8
                  2021-05-25 [BR200411726]; BRPI0411726 A 2006-08-08 [BR200411726]; CN100430397 C 2008-11-05
                  [CN100430397C]; CN1832949 A 2006-09-13 [CN1832949]; ZA200509933 B 2006-12-27 [ZA200509933]; HK1095144
                  A1 2007-04-27 [HK1095144]; AT373003 T 2007-09-15 [ATE373003]; PT1654263 E 2007-11-16 [PT1654263];
                  HRP20070534 T3 2007-12-31 [HRP20070534]; SI1654263 T1 2007-12-31 [SI1654263T]; HRP20070534 T4
                  2011-06-30 [HRP20070534]; SI1654263 T2 2011-06-30 [SI1654263T]; DK1654263 T3 2008-01-07 [DK1654263T];
                  DK1654263 T4 2011-06-14 [DK1654263T]; PL1654263 T3 2008-01-31 [PL1654263]; PL1654263 T5 2011-07-29
                  [PL1654263]; ES2291907 T3 2008-03-01 [ES2291907]; ES2291907 T5 2011-05-30 [ES2291907]; KR10-1013431 B1
                  2011-02-14 [KR101013431]; KR10-2008-0022232 A 2008-03-10 [KR20080022232]; RS51873 B 2012-02-29
                  [RS--51873]; RS20050947 A 2008-04-04 [RS200500947]; VN0007037 B 2008-06-25 [VN---7037B]; IL172563 B
                  2008-07-08 [IL-172563]; GEP20084489 B 2008-09-25 [GE200804489]; UA86026 C2 2009-03-25 [UA--86026];
                  MY139595 A 2009-10-30 [MY-139595]; ME00405 B 2011-10-10 [ME----405]; MEP60208 A 2011-05-10
                  [ME-P60208]; JO2625B1 2011-11-01 [JO---2625]; CY1106936 T1 2012-09-26 [CY1106936]; GC0002959 B
                  2014-09-30 [GC---2959]; DOP2004000941A 2004-12-31 [DO200400941]; AR044705 A1 2005-09-21 [AR--44705];
                  MXPA05013931 A 2006-02-24 [MX2005PA013931]; CR8117A 2006-05-31 [CR---8117]; CO5660266 A2 2006-07-31
                  [CO5660266]; ECSP056245 A 2006-10-17 [EC200506245]; TNSN05329 A1 2007-07-10 [TN0500329];
                  IN5948/DELNP/2005 A 2008-05-09 [IN2005DN05948]; NZ544026 A 2008-08-29 [NZ-544026]; AR094185 A2
                  2015-07-15 [AR--94185]<br>
                  Indian Equivalents: IN5948/DELNP/2005A; IN2005DN05948<br>
                  Title: Phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor<br>
                  By: CYPES STEPHEN HOWARD ([US]); CHEN ALEX MINHUA ([US]); FERLITA RUSSELL R ([US]); HANSEN KARL
                  ([US]); LEE IVAN ([US]); VYDRA VICKY K ([US]); WENSLOW JR ROBERT M ([US])<br>
                  Abstract: The dihydrogenphosphate salt of 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro
                  [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine is a potent inhibitor
                  of dipeptidyl peptidase-IV and is useful for the prevention and/or treatment of non-insulin dependent
                  diabetes mellitus, also referred to as type 2 diabetes. The invention also relates to a crystalline
                  monohydrate of the dihydrogenphosphate salt as well as a process for its preparation, pharmaceutical
                  compositions containing this novel form and methods of use for the treatment of diabetes, obesity, and
                  high blood pressure.<br>

                  Claim: <br>
                  1. A dihydrogenphosphate salt of
                  4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8-
                  H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine of structural<br>
                  formula I: ##STR00008## or a hydrate thereof.<br>
                  2. The salt of claim 1 of structural formula II having the (R)-configuration at the chiral center
                  marked with an * ##STR00009##<br>
                  3. The salt of claim 1 of structural formula III having the (S)-configuration at the chiral center
                  marked with an * ##STR00010##<br>
                  4. The salt of claim 2 characterized in being a crystalline monohydrate.<br>
                  5. The salt of claim 4 characterized by characteristic absorption bands obtained from the X-ray powder
                  diffraction pattern at spectral d-spacings of 7.42, 5.48, and 3.96 angstroms.
                  6. The salt of claim 5 further characterized by characteristic absorption bands obtained from the
                  X-ray powder diffraction pattern at spectral d-spacings of 6.30, 4.75, and 4.48 angstroms.
                  7. The salt of claim 6 further characterized by characteristic absorption bands obtained from the
                  X-ray powder diffraction pattern at spectral d-spacings of 5.85, 5.21, and 3.52 angstroms.
                  8. The salt of claim 7 further characterized by the X-ray powder diffraction pattern of FIG. 1.<br>
                  9. The salt of claim 4 characterized by a solid-state carbon-13 CPMAS nuclear magnetic resonance
                  spectrum showing signals at 169.1, 120.8, and 46.5 ppm.<br>
                  10. The salt of claim 9 further characterized by a solid-state carbon-13 CPMAS nuclear magnetic
                  resonance spectrum showing signals at 159.0, 150.9, and 40.7 ppm.<br>
                  11. The salt of claim 10 further characterized by the solid-state carbon-13 CPMAS nuclear magnetic
                  resonance spectrum of FIG. 2.<br>
                  12. The salt of claim 4 characterized by a solid-state fluorine-19 MAS nuclear magnetic resonance
                  spectrum showing signals at -64.5, -114.7, -136.3, and -146.2 ppm.<br>
                  13. The salt of claim 12 further characterized by a solid-state fluorine-19 MAS nuclear magnetic
                  resonance spectrum showing signals at -96.5, -104.4, -106.3, and -154.5 ppm.<br>
                  14. The salt of claim 13 further characterized by the solid-state fluorine-19 MAS nuclear magnetic
                  resonance spectrum of FIG. 3.<br>
                  15. The salt of claim 4 characterized by the thermogravimetric analysis curve of FIG. 4.<br>
                  16. The salt of claim 4 characterized by the differential scanning calorimetric curve of FIG. 5.<br>
                  17. A pharmaceutical composition comprising a therapeutically effective amount of the salt according
                  to claim 2 in association with one or more pharmaceutically acceptable carriers.<br>
                  18. A pharmaceutical composition comprising a therapeutically effective amount of the salt according
                  to claim 4 in association with one or more pharmaceutically acceptable carriers.<br>
                  19. A method for the treatment of type 2 diabetes comprising administering to a patient in need of
                  such treatment a therapeutically effective amount of the salt according to claim 2 or a hydrate
                  thereof.<br>
                  20. A method for the treatment of type 2 diabetes comprising administering to a patient in need of
                  such treatment a therapeutically effective amount of the salt according to claim 4.<br>
                  21. A process for preparing the salt of claim 2 comprising the step of contacting one equivalent of
                  (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazi-
                  n-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine in an organic<br>
                  solvent or aqueous organic solvent with about a one equivalent of phosphoric acid at a temperature in
                  the range of about 25-100.degree. C.<br>
                  22. The process of claim 21 wherein said organic solvent is a C.sub.1-C.sub.5 linear or branched
                  alkanol.
                  23. The phosphoric acid salt of
                  (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazi-
                  n-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine prepared according to the process of claim 21.<br>
                  24. A process for preparing the crystalline monohydrate of claim 4 comprising the steps of: (a)
                  crystallizing the dihydrogenphosphate salt of structural formula (II): ##STR00011## at 25.degree. C.
                  from a mixture of isopropanol and water, such<br>
                  that the water concentration is above 6.8 weight percent; (b) recovering the resultant solid phase;
                  and (c) removing the solvent therefrom.<br>
                </p>
                <!-- Close Button -->
                <button (click)="closePopup6()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
              </div>
            </div>

          </td>

          <td class="px-2 py-1 w-[80px] text-sm">1</td>
          <td class="px-2 py-1 w-[80px] text-sm">209805</td>
          <td class="px-2 py-1 w-[80px] text-sm">24-nov-2026</td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm">Y</td>
          <td class="px-2 py-1 w-[80px] text-sm">Y</td>

          <td class="px-2 py-1 w-[80px] text-sm">U-2214</td>
          <td class="px-2 py-1 w-[80px] text-sm">16-jan-2018</td>
          <td class="px-2 py-1 w-1/6 text-sm">
            <p>COMPOUND SALT PATENT</p>

            <button (click)="openPopup16()"
              class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
              READ MORE
            </button>

            <div *ngIf="isPopupOpen16" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
              <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                <h2 class="text-lg font-bold" style="color:#312e81;">Remarks</h2>
                <hr>
                <p class="mt-2">
                  COMPOUND SALT PATENT
                </p>
                <hr>
                <!-- Close Button -->
                <button (click)="closePopup16()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
              </div>
            </div>
          </td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
        </tr>



        <hr>


        <!-- ==============  Table-Body 2nd=========== -->

        <tr class="border-b border-gray-300">
          <td class="px-2 py-1 w-1/6">
            <h6 class="text-blue-600 hover:underline"></h6>
            <div class="">
              <p class="text-[#2900FF] font-bold text-sm" style="color:#312e81;">US8080580</p>
              <a
                href="https://worldwide.espacenet.com/patent/search/family/041208284/publication/US8080580B2?q=US8080580">
                <img src="assets/components/espace.png" class="h-1" alt="Google">
              </a>
              <a href="https://patents.google.com/patent/US8080580">
                <img src="assets/components/GooglePatents.png" class="h-2" alt="Espace">
              </a>
            </div>
          </td>

          <td class="px-2 py-1 w-1/6">

            <button (click)="openPopup7()"
              class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
              VIEW PATENT CLAIMS
            </button>

            <div *ngIf="isPopupOpen7" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
              <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                <h2 class="text-lg font-bold" style="color:#312e81;">Patent Claims</h2>
                <hr>
                <p class="mt-2">
                  Patent Information:
                  <span style="padding-left: 800px;"> <button (click)="closePopup7()"
                      class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
                  </span>
                  <br><br>

                  1. Patent Number: US8080580B2; US20100056618A1<br>
                  Assignee: PFIZER ([US])<br>
                  Publication Date: 2011-12-20<br>
                  Application Number: US12/546,306<br>
                  Application Date: 2009-08-24<br>
                  Equivalents: WO2010/023594A1 2010-03-04 [WO201023594]; US8080580 B2 2011-12-20 [US8080580];
                  US20100056618A1 2010-03-04 [US20100056618]; EP2334687 B1 2012-01-04 [EP2334687]; EP2334687 B9
                  2012-08-08 [EP2334687]; EP2334687 A1 2011-06-22 [EP2334687]; CA2733795 C 2013-12-31 [CA2733795];
                  CA2733795 A1 2010-03-04 [CA2733795]; JP4825322 B1 2011-09-16 [JP4825322]; JP2012500842 A 2012-01-12
                  [JP2012500842]; AU2009286380 B2 2011-09-15 [AU2009286380]; AU2009286380 A1 2010-03-04 [AU2009286380];
                  AU2009286380 A8 2011-03-17 [AU2009286380]; TWI387598 B 2013-03-01 [TWI387598]; TW201014863 A
                  2010-04-16 [TW201014863]; SG168919 B 2013-09-13 [SG-168919]; SG168919 A1 2011-03-30 [SG-168919];
                  IL211226 B 2015-02-26 [IL-211226]; IL211226 A 2011-04-28 [IL-211226]; AP2728A 2013-08-31 [AP---2728];
                  AP2011005616 A0 2011-04-30 [AP2011005616]; AP201105616 D0 2011-04-30 [AP201105616]; KR10-1338540 B1
                  2013-12-06 [KR101338540]; KR10-2011-0045093 A 2011-05-03 [KR20110045093]; MA32590 B1 2011-08-01
                  [MA--32590]; NI201100043 A 2011-08-05 [NI201100043]; CN102149717 B 2014-05-14 [CN102149717B];
                  CN102149717 A 2011-08-10 [CN102149717]; EA018492 B1 2013-08-30 [EA--18492]; EA201100266 A1 2011-10-31
                  [EA201100266]; ZA201101341 B 2011-11-30 [ZA201101341]; IN331468 B 2020-02-06 [IN-331468];
                  IN1430/DELNP/2011 A 2011-12-09 [IN2011DN01430]; CU24003 B1 2014-06-27 [CU--24003]; CU20110041 A7
                  2011-12-28 [CU20110041]; AT540040 T 2012-01-15 [ATE540040]; HRP20120104 T1 2012-02-29 [HRP20120104];
                  SI2334687 T1 2012-03-30 [SI2334687T]; PT2334687 E 2012-04-13 [PT2334687]; DK2334687 T3 2012-04-16
                  [DK2334687T]; DK2334687 T5 2012-09-10 [DK2334687T]; ES2380408 T3 2012-05-11 [ES2380408]; ES2380408 T9
                  2013-02-22 [ES2380408]; PL2334687 T3 2012-05-31 [PL2334687]; HK1156616 A1 2012-06-15 [HK1156616];
                  RS52236 B 2012-10-31 [RS--52236]; GEP20135803 B 2013-04-10 [GE201305803]; VN0011532 B 2013-07-25
                  [VN--11532B]; KR10-1446454 B1 2014-10-06 [KR101446454]; KR10-2013-0116078 A 2013-10-22
                  [KR20130116078]; UA103626 C2 2013-11-11 [UA-103626]; CN103497199 B 2015-04-29 [CN103497199B];
                  CN103497199 A 2014-01-08 [CN103497199]; HK1193606 A1 2014-09-26 [HK1193606]; IL236804 B 2019-06-30
                  [IL-236804]; IL236804 A 2015-03-31 [IL-236804]; MY155418 A 2015-10-15 [MY-155418]; BRPI0918841 B1
                  2019-10-08 [BR200918841]; BRPI0918841 B8 2021-05-25 [BR200918841]; BRPI0918841 A2 2015-12-08
                  [BR200918841]; CY1112497 T1 2015-12-09 [CY1112497]; NO2018019 I1 2018-06-26 [NO2018019]; NO2018019 I2
                  2019-02-19 [NO2018019]; NL300943 I2 2018-08-07 [NL-300943I]; UY32073 A 2010-03-26 [UY--32073];
                  PA8840801 A1 2010-04-21 [PA8840801]; AR073138 A1 2010-10-13 [AR--73138]; CR20110077 A 2011-03-09
                  [CR201100077]; DOP2011000058A 2011-03-15 [DO201100058]; SV2011003842 A 2011-03-23 [SV201103842];
                  ECSP11010854 A 2011-03-31 [EC201110854]; MX2011002166 A 2011-04-07 [MX2011002166]; CL2011000394 A1
                  2011-06-17 [CL201100394]; CO6341636 A2 2011-11-21 [CO6341636]; HN2009001652 A 2012-02-13
                  [HN2009001652]; NZ591027 A 2012-11-30 [NZ-591027]; ME01285 A 2013-06-20 [ME---1285]; TH144001 A
                  2015-12-01 [TH-144001]; HUS1800031 I1 2018-08-28 [HU1800031]; LTPA2018510 I1 2018-09-25
                  [LTPA201800510]; LTC2334687 I2 2019-09-10 [LTC2334687]<br>
                  Indian Equivalents: IN331468B; IN-331468; IN1430/DELNP/2011A; IN2011DN01430<br>
                  Title: Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives<br>
                  By: MASCITTI VINCENT ([US]); COLLMAN BENJAMIN M ([US])<br>
                  Abstract: Compounds of Formula (I) are described herein and the uses thereof for the treatment of
                  diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in
                  particular, SGLT2 inhibitors).<br>

                  Claim: <br>
                  1. A compound of Formula (A) or Formula (B) ##STR00051## wherein R.sup.1 is H, (C.sub.1-C.sub.4)alkyl,
                  (C.sub.1-C.sub.4)alkoxy, Cl, F, cyano, fluoro-substituted
                  (C.sub.1-C.sub.2)alkyl, (C.sub.1-C.sub.4)alkyl-SO.sub.2--, or (C.sub.3-C.sub.6)cycloalkyl; and R.sup.2
                  is (C.sub.1-C.sub.4)alkyl, (C.sub.1-C.sub.4)alkoxy, (C.sub.2-C.sub.4)alkynyl, 3-oxetanyloxy,
                  3-tetrahydrofuranyloxy, Cl, F, cyano, fluoro-substituted<br>
                  (C.sub.1-C.sub.2)alkyl, (C.sub.1-C.sub.4)alkyl-SO.sub.2--, (C.sub.3-C.sub.6)cycloalkyl, or a
                  (C.sub.5-C.sub.6)heterocycle having 1 or 2 heteroatoms each independently selected from N, O, or
                  S.<br>
                  2. The compound of claim 1 wherein said compound is a compound of Formula (A).<br>
                  3. The compound of claims 1 or 2 wherein R.sup.1 is H, methyl, ethyl, propyl, isopropyl, methoxy,
                  ethoxy, F, Cl, cyano, --CF.sub.3, cyclopropyl, or cyclobutyl; and R.sup.2 is methyl, ethyl, propyl,
                  isopropyl, methoxy, ethoxy, F, Cl, cyano,<br>
                  --CF.sub.3, --CF.sub.2CH.sub.3, ethynyl, 3-oxetanyloxy, 3-tetrahydrofuranyloxy, or cyclopropyl.
                  4. The compound of claim 3 wherein R.sup.1 is H, methyl, ethyl, isopropyl, methoxy, ethoxy, F, Cl,
                  cyano, --CF.sub.3, or cyclopropyl; and R.sup.2 is methyl, ethyl, isopropyl, methoxy, ethoxy, F, Cl,
                  cyano, --CF.sub.3, --CF.sub.2CH.sub.3,<br>
                  ethynyl, 3-oxetanyloxy, 3-tetrahydrofuranyloxy, or cyclopropyl.<br>
                  5. The compound of claim 4 wherein R.sup.1 is H, methyl, ethyl, methoxy, ethoxy, F, Cl, cyano,
                  --CF.sub.3, or cyclopropyl; and R.sup.2 is methyl, ethyl, methoxy, ethoxy, F, Cl, cyano, --CF.sub.3,
                  --CF.sub.2CH.sub.3, ethynyl, 3-oxetanyloxy,<br>
                  3-tetrahydrofuranyloxy, or cyclopropyl.<br>


                  6. The compound of claim 5 wherein R.sup.1 is methyl, ethyl, F, Cl, cyano, CF.sub.3, or cyclopropyl;
                  and R.sup.2 is methoxy, or ethoxy.<br>

                  8. A compound which is (1S,2S,3S,4R,5S)-5-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-1-hydroxymethyl--
                  6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol.<br>
                  9. A compound selected from the group consisting of:
                  (1S,2S,3S,4S,5S)-1-hydroxymethyl-5-[3-(4-methoxy-benzyl)-4-methyl-phenyl]-
                  -6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol; <br>
                  (1S,2S,3S,4S,5S)-5-[3-(4-ethoxy-benzyl)-4-methyl-phenyl]-1-hydroxymethyl--
                  6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol;
                  (1S,2S,3S,4S,5S)-5-[4-chloro-3-(4-methoxy-benzyl)-phenyl]-1-hydroxymethyl-
                  -6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol; <br>
                  (1S,2S,3S,4S,5S)-5-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-1-hydroxymethyl--
                  6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol;
                  (1S,2S,3S,4S,5S)-5-[4-fluoro-3-(4-methoxy-benzyl)-phenyl]-1-hydroxymethyl-
                  -6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol; <br>
                  (1S,2S,3S,4S,5S)-5-[3-(4-ethoxy-benzyl)-4-fluoro-phenyl]-1-hydroxymethyl--
                  6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol; and
                  (1S,2S,3S,4S,5S)-5-[3-(4-chlorobenzyl)-4-fluorophenyl]-1-hydroxymethyl-6,-
                  8-dioxabicyclo[3.2.1]octane-2,3,4-triol.<br>
                  10. A crystal comprising a compound having the formula (4A): ##STR00052##
                  11. The crystal of claim 10 further comprising L-proline or L-pyroglutamic acid.
                  12. The crystal of claim 10 further comprising L-pyroglutamic acid and having one or more of the
                  following: a) space group of P2(1)2(1)2(1) and unit cell parameters substantially equal to the
                  following: a=7.4907(10) .ANG. .alpha.=90.degree.<br>
                  b=12.8626(15) .ANG. .beta.=90.degree. c=28.029(4) .ANG. .gamma.90.degree.; b) a powder x-ray
                  diffraction pattern comprising 2-theta values of (CuK.alpha. radiation, wavelength of 1.54056 .ANG.)
                  6.4.+-.0.2, 16.7.+-.0.2, 17.4.+-.0.2 and 21.1.+-.0.2; <br>
                  or c) a solid state .sup.13C NMR spectrum comprising peak positions at 16.5.+-.0.2, 131.1.+-.0.2,
                  158.7.+-.0.2, and 181.5.+-.0.2 ppm as determined on a 500 MHz spectrometer relative to crystalline
                  adamantine of 29.5 ppm.<br>
                  13. The crystal of claim 10 further comprising L-pyroglutamic acid wherein the crystal is a co-crystal
                  comprising the compound of formula (4A) and L-pyroglutamic acid in a 1:1 stoichiometric ratio.<br>
                  14. The crystal of claim 10 further comprising L-pyroglutamic acid and having a) a powder x-ray
                  diffraction pattern comprising a 2-theta value of (CuK.alpha. radiation, wavelength of 1.54056 .ANG.)
                  6.4.+-.0.2; and b) a solid state .sup.13C<br>
                  NMR spectrum comprising peak positions at 16.5.+-.0.2, 158.7.+-.0.2, and 181.5.+-.0.2 ppm as
                  determined on a 500 MHz spectrometer relative to crystalline adamantine of 29.5 ppm.
                  15. The crystal of claim 10 further comprising L-proline and having one or more of the following: a)
                  space group of C2 and unit cell parameters substantially equal to the following: a=32.8399(16) .ANG.
                  .alpha.=90.degree. b=7.2457(4) .ANG. <br>
                  .beta.=101.268(5).degree. c=11.8023(6) .ANG. .gamma.=90.degree.; or b) a powder x-ray diffraction
                  pattern comprising 2-theta values of (CuK.alpha. radiation, wavelength of 1.54056 .ANG.) 7.6.+-.0.2,
                  12.1.+-.0.2, 20.3.+-.0.2 and 28.8.+-.0.2.<br>
                  16. A pharmaceutical composition comprising (i) a compound of any of claims 1 through 9 or a crystal
                  of any of claims 10-15; and (ii) a pharmaceutically acceptable excipient, diluent, or carrier.<br>

                  17. A method for treating obesity and obesity-related disorders in animals comprising the step of
                  administering to an animal in need of such treatment a therapeutically effective amount of a compound
                  of any one of claims 1 through 9 or a<br>
                  therapeutically effective amount of a crystal of any one of claims 10 through 15.
                  18. A method for treating or delaying the progression or onset of Type 2 diabetes and diabetes-related
                  disorders in animals comprising the step of administering to an animal in need of such treatment a
                  therapeutically effective amount of a<br>
                  compound of any one of claims 1 through 9 or a therapeutically effective amount of a crystal of any
                  one of claims 10 through 15.<br>
                  19. A method for treating obesity and obesity-related disorders in animals comprising the step of
                  administering to an animal in need of such treatment a pharmaceutical composition of claim 16.<br>
                  20. A method for treating or delaying the progression or onset of Type 2 diabetes and diabetes-related
                  disorders in animals comprising the step of administering to an animal in need of such treatment a
                  pharmaceutical composition of claim 16.<br>


                </p>
                <!-- Close Button -->
                <button (click)="closePopup7()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
              </div>
            </div>
          </td>

          <td class="px-2 py-1 w-[80px] text-sm">1</td>
          <td class="px-2 py-1 w-[80px] text-sm">209805</td>
          <td class="px-2 py-1 w-[80px] text-sm">13-JULY-2030</td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm">Y</td>
          <td class="px-2 py-1 w-[80px] text-sm">Y</td>

          <td class="px-2 py-1 w-[80px] text-sm">U-2214</td>
          <td class="px-2 py-1 w-[80px] text-sm">16-jan-2018</td>
          <td class="px-2 py-1 w-1/6 text-sm">
            <p>COMPOUND PATENT</p>
            <button (click)="openPopup17()"
              class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
              READ MORE
            </button>

            <div *ngIf="isPopupOpen17" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
              <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                <h2 class="text-lg font-bold" style="color:#312e81;">Remarks</h2>
                <hr>
                <p class="mt-2">
                  COMPOUND PATENT
                </p>
                <hr>
                <!-- Close Button -->
                <button (click)="closePopup17()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
              </div>
            </div>
          </td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
        </tr>

        <hr>
        <!-- ==============  Table-Body 3rd=========== -->

        <tr class="border-b border-gray-300">
          <td class="px-2 py-1 w-1/6">
            <h6 class="text-blue-600 hover:underline"></h6>
            <div class="">
              <p class="text-[#2900FF] font-bold text-sm" style="color:#312e81;">US9439901</p>
              <a
                href="https://worldwide.espacenet.com/patent/search/family/041208284/publication/US8080580B2?q=US8080580">
                <img src="assets/components/espace.png" class="h-1" alt="Google">
              </a>
              <a href="https://patents.google.com/patent/US8080580">
                <img src="assets/components/GooglePatents.png" class="h-2" alt="Espace">
              </a>
            </div>
          </td>

          <td class="px-2 py-1 w-1/6">
            <button (click)="openPopup8()"
              class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
              VIEW PATENT CLAIMS
            </button>

            <div *ngIf="isPopupOpen8" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
              <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                <h2 class="text-lg font-bold" style="color:#312e81;">Patent Claims</h2>
                <hr>
                <p class="mt-2">


                  Patent Information: <span style="padding-left: 800px;"> <button (click)="closePopup8()"
                      class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
                  </span>
                  <br><br>

                  1. Patent Number: US9439901B2; US20150065512A1<br>
                  Assignee: PFIZER ([US])<br>
                  Publication Date: 2016-09-13<br>
                  Application Number: US14/535,556<br>
                  Application Date: 2014-11-07<br>
                  Equivalents: WO2011/051864A1 2011-05-05 [WO201151864]; US8669380 B2 2014-03-11 [US8669380];
                  US20120184486A1 2012-07-19 [US20120184486];
                  US9308204 B2 2016-04-12 [US9308204]; US9439901 B2 2016-09-13 [US9439901]; US9439902 B2 2016-09-13
                  [US9439902]; US20150065512A1 2015-03-05 [US20150065512]; US20150065513A1 2015-03-05 [US20150065513];
                  US20150065565A1 2015-03-05 [US20150065565]; US20130225487A1 2013-08-29 [US20130225487]; EP2496583 B1
                  2014-12-10 [EP2496583]; EP2496583 A1 2012-09-12 [EP2496583]; CA2777857 C 2014-12-02 [CA2777857];
                  CA2777857 A1 2011-05-05 [CA2777857]; JP5696156 B2 2015-04-08 [JP5696156]; JP2013509393 A 2013-03-14
                  <br>
                  [JP2013509393]; AU2010310956 B2 2014-05-08 [AU2010310956]; AU2010310956 A1 2012-06-07 [AU2010310956];
                  AP3099A 2015-01-31 [AP---3099]; AP2012006281 A0 2012-06-30 [AP2012006281]; KR10-1426180 B1 2014-07-31
                  [KR101426180]; KR10-2012-0093321 A 2012-08-22 [KR20120093321]; EA021983 B1 2015-10-30 [EA--21983];
                  EA201290267 A1 2012-12-28 [EA201290267]; VN0021374 B 2019-07-25 [VN--21374B]; VN32142 A 2013-01-25
                  [VN--32142]; ZA201203486 B 2013-07-31 [ZA201203486]; UA103416 C2 2013-10-10 [UA-103416]; PT2496583 E
                  2015-01-14 [PT2496583]; ES2527179 T3 2015-01-21 [ES2527179]; DK2496583 T3 2015-02-02 [DK2496583T];
                  SI2496583 T1 2015-02-27 [SI2496583T]; HRP20150107 T1 2015-03-13 [HRP20150107]; PL2496583 T3 2015-04-30
                  [PL2496583]; ME02016 B 2015-05-20 [ME---2016]; RS53827 B1 2015-06-30 [RS--53827]; IN278443 B
                  2016-12-30 [IN-278443]; IN4720/DELNP/2012 A 2015-12-04 [IN2012DN04720]; CY1115949 T1 2017-01-25
                  [CY1115949]; ECSP12011946 A 2012-07-31 [EC201211946]; CR20120289 A 2012-09-26 [CR201200289]; NZ599945
                  A 2014-05-30 [NZ-599945]<br>
                  Indian Equivalents: IN278443B; IN-278443; IN4720/DELNP/2012A; IN2012DN04720<br>
                  Title: Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives<br>
                  By: MASCITTI VINCENT ([US])<br>
                  Abstract: Compounds of Formula (A) and (B) are described herein and the uses thereof for the treatment
                  of diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in
                  particular, SGLT2 inhibitors).<br>

                  Claim: <br>
                  1. A method for treating obesity in humans comprising the step of administering to a human in need of
                  such treatment a therapeutically effective amount of a pharmaceutical<br>
                  composition comprising: (i) (1S,2S,3S,4R,5S)-5-[-4-chloro-3-(4-ethoxy-benzyl)-phenyl]-1-hydroxymethyl-
                  -6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol; (ii) a pharmaceutically acceptable excipient, diluent, or
                  carrier and (iii) sitagliptin; or a<br>
                  pharmaceutically acceptable salt thereof.<br>
                  2. A method for treating Type 2 diabetes in humans comprising the step of administering to a human in
                  need of such treatment a therapeutically effective amount of a pharmaceutical composition comprising:
                  (i)<br>
                  (1S,2S,3S,4R,5S)-5-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-1-hydroxymethyl--
                  6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol; (ii) a pharmaceutically acceptable excipient, diluent, or
                  carrier and (iii) sitagliptin; or a pharmaceutically acceptable salt<br>
                  thereof.<br>

                </p>
                <!-- Close Button -->
                <button (click)="closePopup8()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
              </div>
            </div>

          </td>

          <td class="px-2 py-1 w-[80px] text-sm">1</td>
          <td class="px-2 py-1 w-[80px] text-sm">209805</td>
          <td class="px-2 py-1 w-[80px] text-sm">21-OCT-2030</td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>

          <td class="px-2 py-1 w-[80px] text-sm">U-2214</td>
          <td class="px-2 py-1 w-[80px] text-sm">16-jan-2018</td>
          <td class="px-2 py-1 w-1/6 text-sm">
            <p>MOU PATENT</p>

            <button (click)="openPopup18()"
              class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
              READ MORE
            </button>

            <div *ngIf="isPopupOpen18" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
              <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                <h2 class="text-lg font-bold" style="color:#312e81;">Remarks</h2>
                <hr>
                <p class="mt-2">
                  MOU PATENT
                </p>
                <hr>
                <!-- Close Button -->
                <button (click)="closePopup18()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
              </div>
            </div>
          </td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
        </tr>

        <hr>

        <!-- ==============  Table-Body 4TH=========== -->

        <tr class="border-b border-gray-300">
          <td class="px-2 py-1 w-1/6">
            <h6 class="text-blue-600 hover:underline"></h6>
            <div class="">
              <p class="text-[#2900FF] font-bold text-sm" style="color:#312e81;">US9308204</p>
              <a
                href="https://worldwide.espacenet.com/patent/search/family/041208284/publication/US8080580B2?q=US8080580">
                <img src="assets/components/espace.png" class="h-1" alt="Google">
              </a>
              <a href="https://patents.google.com/patent/US8080580">
                <img src="assets/components/GooglePatents.png" class="h-2" alt="Espace">
              </a>
            </div>
          </td>

          <td class="px-2 py-1 w-1/6">
            <button (click)="openPopup9()"
              class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
              VIEW PATENT CLAIMS
            </button>

            <div *ngIf="isPopupOpen9" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
              <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                <h2 class="text-lg font-bold" style="color:#312e81;">Patent Claims</h2>
                <hr>
                <p class="mt-2">

                  Patent Information:<span style="padding-left: 800px;"> <button (click)="closePopup9()"
                      class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
                  </span>
                  <br><br>

                  1. Patent Number: US9308204B2; US20150065513A1<br>
                  Assignee: PFIZER ([US])<br>
                  Publication Date: 2016-04-12<br>
                  Application Number: US14/535,630<br>
                  Application Date: 2014-11-07<br>
                  Equivalents: WO2011/051864A1 2011-05-05 [WO201151864]; US8669380 B2 2014-03-11 [US8669380];
                  US20120184486A1 2012-07-19 [US20120184486]; US9308204 B2 2016-04-12 [US9308204]; US9439901 B2
                  2016-09-13 [US9439901]; US9439902 B2 2016-09-13 [US9439902]; US20150065512A1 2015-03-05
                  [US20150065512]; US20150065513A1 2015-03-05 [US20150065513]; US20150065565A1 2015-03-05
                  [US20150065565]; US20130225487A1 2013-08-29 [US20130225487]; EP2496583 B1 2014-12-10 [EP2496583];
                  EP2496583 A1 2012-09-12 [EP2496583]; CA2777857 C 2014-12-02 [CA2777857]; CA2777857 A1 2011-05-05
                  [CA2777857]; JP5696156 B2 2015-04-08 [JP5696156]; JP2013509393 A 2013-03-14 [JP2013509393];
                  AU2010310956 B2 2014-05-08 [AU2010310956]; AU2010310956 A1 2012-06-07 [AU2010310956]; AP3099A
                  2015-01-31 [AP---3099]; AP2012006281 A0 2012-06-30 [AP2012006281]; KR10-1426180 B1 2014-07-31
                  [KR101426180]; KR10-2012-0093321 A 2012-08-22 [KR20120093321]; EA021983 B1 2015-10-30 [EA--21983];
                  EA201290267 A1 2012-12-28 [EA201290267]; VN0021374 B 2019-07-25 [VN--21374B]; VN32142 A 2013-01-25
                  [VN--32142]; ZA201203486 B 2013-07-31 [ZA201203486]; UA103416 C2 2013-10-10 [UA-103416]; PT2496583 E
                  2015-01-14 [PT2496583]; ES2527179 T3 2015-01-21 [ES2527179]; DK2496583 T3 2015-02-02 [DK2496583T];
                  SI2496583 T1 2015-02-27 [SI2496583T]; HRP20150107 T1 2015-03-13 [HRP20150107]; PL2496583 T3 2015-04-30
                  [PL2496583]; ME02016 B 2015-05-20 [ME---2016]; RS53827 B1 2015-06-30 [RS--53827]; IN278443 B
                  2016-12-30 [IN-278443]; IN4720/DELNP/2012 A 2015-12-04 [IN2012DN04720]; CY1115949 T1 2017-01-25
                  [CY1115949]; ECSP12011946 A 2012-07-31 [EC201211946]; CR20120289 A 2012-09-26 [CR201200289]; NZ599945
                  A 2014-05-30 [NZ-599945]<br>
                  Indian Equivalents: IN278443B; IN-278443; IN4720/DELNP/2012A; IN2012DN04720<br>
                  Title: Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives<br>
                  By: MASCITTI VINCENT ([US])<br>
                  Abstract: Compounds of Formula (A) and (B) are described herein and the uses thereof for the treatment
                  of diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in
                  particular, SGLT2 inhibitors).<br>

                  Claim: <br>
                  1. A pharmaceutical composition comprising: (i)
                  (1S,2S,3S,4R,5S)-5-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-1-hydroxymethyl--
                  6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol; (ii)<br>
                  a pharmaceutically acceptable excipient, diluent, or carrier; and (iii) sitagliptin.<br>
                  2. A pharmaceutical composition comprising: (i)
                  (1S,2S,3S,4R,5S)-5-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-1-hydroxymethyl--
                  6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol; (ii) a pharmaceutically acceptable excipient, diluent, or
                  carrier; and<br>
                  (iii) metformin.<br>
                  3. The composition of claim 1 wherein
                  (1S,2S,3S,4R,5S)-5-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-1-hydroxymethyl--
                  6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol is present in a therapeutically effective amount.<br>
                  4. The composition of claim 2 wherein
                  (1S,2S,3S,4R,5S)-5-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-1-hydroxymethyl--
                  6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol is present in a therapeutically effective amount.<br>
                </p>
                <!-- Close Button -->
                <button (click)="closePopup9()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
              </div>
            </div>
          </td>

          <td class="px-2 py-1 w-[80px] text-sm">1</td>
          <td class="px-2 py-1 w-[80px] text-sm">209805</td>
          <td class="px-2 py-1 w-[80px] text-sm">21-OCT-2030</td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm">Y</td>

          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm">16-jan-2018</td>
          <td class="px-2 py-1 w-1/6 text-sm">
            <p>COMPOSITION PATENT</p>
            <button (click)="openPopup18()"
              class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
              READ MORE
            </button>

            <div *ngIf="isPopupOpen18" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
              <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                <h2 class="text-lg font-bold" style="color:#312e81;">Remarks</h2>
                <hr>
                <p class="mt-2">
                  COMPOSITION PATENT
                </p>
                <hr>
                <!-- Close Button -->
                <button (click)="closePopup18()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
              </div>
            </div>
          </td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
        </tr>
        <hr>


        <!-- ==============  Table-Body 5TH=========== -->

        <tr class="border-b border-gray-300">
          <td class="px-2 py-1 w-1/6">
            <h6 class="text-blue-600 hover:underline"></h6>
            <div class="">
              <p class="text-[#2900FF] font-bold text-sm" style="color:#312e81;">US7326708*PED</p>
              <a
                href="https://worldwide.espacenet.com/patent/search/family/041208284/publication/US8080580B2?q=US8080580">
                <img src="assets/components/espace.png" class="h-1" alt="Google">
              </a>
              <a href="https://patents.google.com/patent/US8080580">
                <img src="assets/components/GooglePatents.png" class="h-2" alt="Espace">
              </a>
            </div>
          </td>

          <td class="px-2 py-1 w-1/6">
            <button (click)="openPopup10()"
              class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
              VIEW PATENT CLAIMS
            </button>

            <div *ngIf="isPopupOpen10" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
              <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                <h2 class="text-lg font-bold" style="color:#312e81;">Patent Claims</h2>
                <hr>
                <p class="mt-2">
                  Patent Information:
                  <span style="padding-left: 800px;"> <button (click)="closePopup10()"
                      class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
                  </span>
                  <br><br>


                  1. Patent Number: US7326708B2; US20050032804A1<br>
                  Assignee: MERCK SHARP &amp; DOHME ([US])<br>
                  Publication Date: 2008-02-05<br>
                  Application Number: US10/874,992<br>
                  Application Date: 2004-06-23<br>
                  Equivalents: WO2005/003135A1 2005-01-13 [WO200503135]; US7326708 B2 2008-02-05 [US7326708];
                  US20050032804A1 2005-02-10 [US20050032804]; EP1654263 B1 2007-09-12 [EP1654263]; EP1654263 B2
                  2011-02-23 [EP1654263]; EP1654263 A1 2006-05-10 [EP1654263]; CA2529400 C 2007-10-09 [CA2529400];
                  CA2529400 A1 2005-01-13 [CA2529400]; DE602004008938 D1 2007-10-25 [DE602004008938]; DE602004008938 T2
                  2008-08-07 [DE602004008938]; DE602004008938 T3 2012-01-12 [DE602004008938]; JP4463768 B2 2010-05-19
                  [JP4463768]; JP2006516268 A 2006-06-29 [JP2006516268]; AU2004253889 B2 2008-04-24 [AU2004253889];
                  AU2004253889 A1 2005-01-13 [AU2004253889]; TWI347185 B 2011-08-21 [TWI347185]; TW200524610 A
                  2005-08-01 [TW200524610]; IS2792B 2012-08-15 [IS---2792B]; IS8183A 2005-12-15 [IS---8183]; SG118516 B
                  2007-11-30 [SG-118516]; SG118516 A1 2006-02-28 [SG-118516]; KR10-1016569 B1 2011-02-22 [KR101016569];
                  KR10-2006-0026061 A 2006-03-22 [KR20060026061]; NO335371 B1 2014-12-01 [NO-335371]; NO20060362 L
                  2006-03-23 [NO20060362]; MA27861 A1 2006-04-03 [MA--27861]; EA009042 B1 2007-10-26 [EA---9042];
                  EA200600095 A1 2006-06-30 [EA200600095]; BRPI0411726 B1 2017-12-12 [BR200411726]; BRPI0411726 B8
                  2021-05-25 [BR200411726]; BRPI0411726 A 2006-08-08 [BR200411726]; CN100430397 C 2008-11-05
                  [CN100430397C]; CN1832949 A 2006-09-13 [CN1832949]; ZA200509933 B 2006-12-27 [ZA200509933]; HK1095144
                  A1 2007-04-27 [HK1095144]; AT373003 T 2007-09-15 [ATE373003]; PT1654263 E 2007-11-16 [PT1654263];
                  HRP20070534 T3 2007-12-31 [HRP20070534]; SI1654263 T1 2007-12-31 [SI1654263T]; HRP20070534 T4
                  2011-06-30 [HRP20070534]; SI1654263 T2 2011-06-30 [SI1654263T]; DK1654263 T3 2008-01-07 [DK1654263T];
                  DK1654263 T4 2011-06-14 [DK1654263T]; PL1654263 T3 2008-01-31 [PL1654263]; PL1654263 T5 2011-07-29
                  [PL1654263]; ES2291907 T3 2008-03-01 [ES2291907]; ES2291907 T5 2011-05-30 [ES2291907]; KR10-1013431 B1
                  2011-02-14 [KR101013431]; KR10-2008-0022232 A 2008-03-10 [KR20080022232]; RS51873 B 2012-02-29
                  [RS--51873]; RS20050947 A 2008-04-04 [RS200500947]; VN0007037 B 2008-06-25 [VN---7037B]; IL172563 B
                  2008-07-08 [IL-172563]; GEP20084489 B 2008-09-25 [GE200804489]; UA86026 C2 2009-03-25 [UA--86026];
                  MY139595 A 2009-10-30 [MY-139595]; ME00405 B 2011-10-10 [ME----405]; MEP60208 A 2011-05-10
                  [ME-P60208]; JO2625B1 2011-11-01 [JO---2625]; CY1106936 T1 2012-09-26 [CY1106936]; GC0002959 B
                  2014-09-30 [GC---2959]; DOP2004000941A 2004-12-31 [DO200400941]; AR044705 A1 2005-09-21 [AR--44705];
                  MXPA05013931 A 2006-02-24 [MX2005PA013931]; CR8117A 2006-05-31 [CR---8117]; CO5660266 A2 2006-07-31
                  [CO5660266]; ECSP056245 A 2006-10-17 [EC200506245]; TNSN05329 A1 2007-07-10 [TN0500329];
                  IN5948/DELNP/2005 A 2008-05-09 [IN2005DN05948]; NZ544026 A 2008-08-29 [NZ-544026]; AR094185 A2
                  2015-07-15 [AR--94185]<br>
                  Indian Equivalents: IN5948/DELNP/2005A; IN2005DN05948<br>
                  Title: Phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor<br>
                  By: CYPES STEPHEN HOWARD ([US]); CHEN ALEX MINHUA ([US]); FERLITA RUSSELL R ([US]); HANSEN KARL
                  ([US]); LEE IVAN ([US]); VYDRA VICKY K ([US]); WENSLOW JR ROBERT M ([US])<br>
                  Abstract: The dihydrogenphosphate salt of 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro
                  [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine is a potent inhibitor
                  of dipeptidyl peptidase-IV and is useful for the prevention and/or treatment of non-insulin dependent
                  diabetes mellitus, also referred to as type 2 diabetes. The invention also relates to a crystalline
                  monohydrate of the dihydrogenphosphate salt as well as a process for its preparation, pharmaceutical
                  compositions containing this novel form and methods of use for the treatment of diabetes, obesity, and
                  high blood pressure.<br>

                  Claim: <br>
                  1. A dihydrogenphosphate salt of
                  4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8-
                  H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine of structural
                  formula I: ##STR00008## or a hydrate thereof.<br>
                  2. The salt of claim 1 of structural formula II having the (R)-configuration at the chiral center
                  marked with an * ##STR00009##<br>
                  3. The salt of claim 1 of structural formula III having the (S)-configuration at the chiral center
                  marked with an * ##STR00010##<br>
                  4. The salt of claim 2 characterized in being a crystalline monohydrate.
                  5. The salt of claim 4 characterized by characteristic absorption bands obtained from the X-ray powder
                  diffraction pattern at spectral d-spacings of 7.42, 5.48, and 3.96 angstroms.
                  6. The salt of claim 5 further characterized by characteristic absorption bands obtained from the
                  X-ray powder diffraction pattern at spectral d-spacings of 6.30, 4.75, and 4.48 angstroms.
                  7. The salt of claim 6 further characterized by characteristic absorption bands obtained from the
                  X-ray powder diffraction pattern at spectral d-spacings of 5.85, 5.21, and 3.52 angstroms.
                  8. The salt of claim 7 further characterized by the X-ray powder diffraction pattern of FIG. 1.<br>
                  9. The salt of claim 4 characterized by a solid-state carbon-13 CPMAS nuclear magnetic resonance
                  spectrum showing signals at 169.1, 120.8, and 46.5 ppm.
                  10. The salt of claim 9 further characterized by a solid-state carbon-13 CPMAS nuclear magnetic
                  resonance spectrum showing signals at 159.0, 150.9, and 40.7 ppm.
                  11. The salt of claim 10 further characterized by the solid-state carbon-13 CPMAS nuclear magnetic
                  resonance spectrum of FIG. 2.<br>
                  12. The salt of claim 4 characterized by a solid-state fluorine-19 MAS nuclear magnetic resonance
                  spectrum showing signals at -64.5, -114.7, -136.3, and -146.2 ppm.
                  13. The salt of claim 12 further characterized by a solid-state fluorine-19 MAS nuclear magnetic
                  resonance spectrum showing signals at -96.5, -104.4, -106.3, and -154.5 ppm.
                  14. The salt of claim 13 further characterized by the solid-state fluorine-19 MAS nuclear magnetic
                  resonance spectrum of FIG. 3.<br>
                  15. The salt of claim 4 characterized by the thermogravimetric analysis curve of FIG. 4.<br>
                  16. The salt of claim 4 characterized by the differential scanning calorimetric curve of FIG. 5.<br>
                  17. A pharmaceutical composition comprising a therapeutically effective amount of the salt according
                  to claim 2 in association with one or more pharmaceutically acceptable carriers.<br>
                  18. A pharmaceutical composition comprising a therapeutically effective amount of the salt according
                  to claim 4 in association with one or more pharmaceutically acceptable carriers.<br>
                  19. A method for the treatment of type 2 diabetes comprising administering to a patient in need of
                  such treatment a therapeutically effective amount of the salt according to claim 2 or a hydrate
                  thereof.<br>
                  20. A method for the treatment of type 2 diabetes comprising administering to a patient in need of
                  such treatment a therapeutically effective amount of the salt according to claim 4.<br>
                  21. A process for preparing the salt of claim 2 comprising the step of contacting one equivalent of
                  (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazi-
                  n-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine in an organic<br>
                  solvent or aqueous organic solvent with about a one equivalent of phosphoric acid at a temperature in
                  the range of about 25-100.degree. C.<br>
                  22. The process of claim 21 wherein said organic solvent is a C.sub.1-C.sub.5 linear or branched
                  alkanol.<br>
                  23. The phosphoric acid salt of
                  (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazi-
                  n-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine prepared according to the process of claim 21.<br>
                  24. A process for preparing the crystalline monohydrate of claim 4 comprising the steps of: (a)
                  crystallizing the dihydrogenphosphate salt of structural formula (II): ##STR00011## at 25.degree. C.
                  from a mixture of isopropanol and water, such<br>
                  that the water concentration is above 6.8 weight percent; (b) recovering the resultant solid phase;
                  and (c) removing the solvent therefrom.<br>
                </p>
                <!-- Close Button -->
                <button (click)="closePopup10()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
              </div>
            </div>
          </td>

          <td class="px-2 py-1 w-[80px] text-sm">1</td>
          <td class="px-2 py-1 w-[80px] text-sm">209805</td>
          <td class="px-2 py-1 w-[80px] text-sm">24-may-2027</td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>

          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-1/6 text-sm">
            <p>COMPOUND SALT PATENT</p>
            <button (click)="openPopup20()"
              class="bg-yellow-600 text-white px-3 py-1 rounded hover:bg-yellow-700 text-sm">
              READ MORE
            </button>

            <div *ngIf="isPopupOpen20" class="fixed inset-0 flex items-center justify-center bg-black bg-opacity-50">
              <div class="bg-white p-6 rounded shadow-lg w-3/4 max-h-[80vh] overflow-y-auto">
                <h2 class="text-lg font-bold" style="color:#312e81;">Remarks</h2>
                <hr>
                <p class="mt-2">
                  COMPOUND SALT PATENT
                </p>
                <hr>
                <!-- Close Button -->
                <button (click)="closePopup20()" class="mt-4 bg-red-500 text-white px-4 py-2 rounded">Close</button>
              </div>
            </div>
          </td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
        </tr>


      </tbody>
    </table>
  </div>

  <div class="obexclusivitydata">

    <h4 class="obtext" style="padding: 25px 0 10px 0; font-size: 20px;">OB Exclusivity Data :</h4>

    <table class="w-full border border-gray-300">
      <thead class="bg-gray-800 text-white text-sm">
        <tr>
          <th class="px-2 py-1 text-left">Product</th>
          <th class="px-2 py-1 text-left">Product No.</th>
          <th class="px-2 py-1 text-left">Exclusive Code</th>
          <th class="px-2 py-1 text-left">Exclusive Expiration</th>
          <th class="px-2 py-1 text-left">Application No.</th>
          <th class="px-2 py-1 text-left">Application Type</th>
          <th class="px-2 py-1 text-left">Notes</th>
          <th class="px-2 py-1 text-left">Remarks</th>
          <th class="px-2 py-1 text-left">PDF, CSV, Text File downloadable format</th>
        </tr>
      </thead>
      <tbody style="background-color:#f8faff;">
        <tr class="border-b border-gray-300">
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm">1</td>
          <td class="px-2 py-1 w-[80px] text-sm">M-275</td>
          <td class="px-2 py-1 w-[80px] text-sm">17-Sep-2024</td>
          <td class="px-2 py-1 w-[80px] text-sm">209805</td>
          <td class="px-2 py-1 w-[80px] text-sm">N</td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
          <td class="px-2 py-1 w-[80px] text-sm"></td>
        </tr>
      </tbody>
    </table>
  </div>

  <hr style="border: 5px solid blue;">
  <!--view patent modal-->
  <!-- Trigger Button -->
  <div>
    <button *ngIf="viewPatent" class="btn btn-outline-primary btn-sm " style="z-index: 9;" data-bs-toggle="modal"
      data-bs-target="#viewPatentModal">
      <i class="fas fa-eye"></i> View Patent Information
    </button>
  </div>

  <!-- Modal -->
  <!-- Trigger Button -->
<div>
  <button class="btn btn-outline-primary btn-sm" data-bs-toggle="modal" data-bs-target="#viewPatentModal">
    <i class="fas fa-eye"></i> View Patent Claims
  </button>
</div>

<!-- Modal -->
<div class="modal fade" id="viewPatentModal" tabindex="-1" aria-labelledby="viewPatentModalLabel" aria-hidden="true" style="margin-top: 5%;">
  <div class="modal-dialog modal-dialog-centered modal-lg">
    <div class="modal-content p-4" style="max-height: 90vh; overflow-y: auto;">
      
      <div class="modal-header border-bottom-0">
        <h5 class="modal-title text-primary fw-bold" id="viewPatentModalLabel">Patent Claims</h5>
        <button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button>
      </div>

      <div class="modal-body pt-0" *ngIf="selectedPatent">
        <h6 class="text-dark fw-bold">Patent Information:</h6>
        <p class="text-muted mb-2">{{ selectedPatent.notes }}</p>
      </div>

      <div class="modal-footer border-top-0">
        <button type="button" class="btn btn-danger" data-bs-dismiss="modal">Close</button>
      </div>

    </div>
  </div>
</div>

<div class="modal fade" id="remarkModal" tabindex="-1" aria-labelledby="remarkModalLabel" aria-hidden="true" style="margin-top: 5%;">
  <div class="modal-dialog modal-dialog-centered modal-lg">
    <div class="modal-content p-4" style="max-height: 90vh; overflow-y: auto;">
      
      <div class="modal-header border-bottom-0">
        <h5 class="modal-title text-primary fw-bold" id="remarkModalLabel">Patent Remarks</h5>
        <button type="button" class="btn-close" data-bs-dismiss="modal" aria-label="Close"></button>
      </div>

      <div class="modal-body pt-0" *ngIf="selectedPatent">
        <h6 class="text-dark fw-bold">Remarks:</h6>
        <p class="text-muted mb-2">{{ selectedPatent.remark_s }}</p>
      </div>

      <div class="modal-footer border-top-0">
        <button type="button" class="btn btn-danger" data-bs-dismiss="modal">Close</button>
      </div>

    </div>
  </div>
</div>

</ng-container>